Cryptocurrencies: 2613 / Markets: 20892 Market Cap: 24h Vol:

Description

Description


The company Biogen International Business Company located in Ireland will start up with the collaboration of companies and scientists from around the world a project to extend human life, thanks to blockchain technology. 

Full Name Biogen (HTER)
Start Date 2018-11-10
Algorithm ETH Token
Proof Type N/A
Website https://icobiogen.com
Twitter @IBiogen
Facebook N/A
Reddit N/A
Block Number N/A
Block Time N/A
Block Reward N/A
Previous Total Coins Mined N/A
Net Hashes Per Second N/A
ICO Details

ICO Details


The company Biogen International Business Company located in Ireland will start up with the collaboration of companies and scientists from around the world a project to extend human life, thanks to blockchain technology.

Team:

  • Pablo Cervera: Partner and Ceo. 
  • Sandra Miriam Vera: Partner & Sales manager. 
  • Naviin Kapoor: Ico Advisor and expert Icobench. 
  • Carlo Buonpane: Ico Advisor and expert Icobench. 

Biogen Pre-ICO began on March 1, 2019, and has ended at March 31, 2019, with a starting price of 0.00045 ETH. Biogen ICO began on April 1, 2019. The ICO token supply represents 40% of the total token supply, so there is a total of 200,000,000,000 HTER tokens available (including Pre-ICO), for 0.00054 ETH. The ICO funding target is 3,000,000 USD, the funding cap is 400,000,000 USD and is expected to end on September 30, 2019, or when the funding cap is reached.

Token Reserve Split (60%):

  • 51% Company;
  • 9% Executives, Workers, Collaborators.
ICO Status Ongoing
Token Supply 5000000000
Start Date 2019-04-01
End Date 2019-09-30
Fund Raised (BTC) N/A
Fund Raised (USD) 750000
Start Price (USD) 0.00054
Security Audit Company N/A
ICO Legal Form Corporation
ICO Jurisdiction Ireland
Legal Advisers N/A
Blog https://medium.com/@icoBiogen
White Paper https://icobiogen.com/wp-content/uploads/2018/12/WHITE-PAPER.pdf
Get Crypto Newsletter
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer